FDA: Hospira recalls three lots of hydromorphone HCL injection

Editor's Note

The Food & Drug Administration (FDA) on March 5 announced the recall by Hospira (Lake Forest, Illinois) of three lots of hydromorphone HCL injection, USP Cll 10 mg/mL, 1 mL in 2 mL single dose vials.

The recall was initiated because units from these lots may be empty or cracked at the bottom of the glass vial. Cracked vials my compromise sterility of the product, and exposure to cracked vials may be associated with sharps injuries.

Lot numbers are 71330DD (NDC 0409-2634-01) as well as 691853F and 700753F (NDC 0703-0110-01-Teva lots).

Posted 03/05/2018] AUDIENCE: Pharmacy, Risk Manager ISSUE: Hospira is voluntarily recalling three lots of Hydromorphone HCl Injection, USP CII 10 mg/mL, 1 mL in 2 mL Single Dose Vials lot numbers 71330DD (NDC 0409-2634-01), and 691853F and 700753F (NDC 0703-0110-01 - Teva lots) to the hospital/institution level.

Read More >>